Atlas FDA

VIEWPOINT CK SYSTEM

FDA premarket approval P010018/S005 · decided 2004-03-16

Approval details

PMA number
P010018
Supplement
S005
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VIEWPOINT CK SYSTEM
Generic name
Electrosurgical, radio frequency, refractive correction
Applicant
Refractec, Inc.
Date received
2003-08-27
Decision date
2004-03-16
Days to decision
202 days
Decision code
APPR
Product code
MWD
Advisory committee
Ophthalmic
Expedited review
No
Location
Irvine, CA
Statement
APPROVAL FOR THE VIEWPOINT CK SYSTEM. THE DEVICE IS INDICATED FOR THE TEMPORARY INDUCTION OF MYOPIA (-1.00 D TO -2.00 D) TO IMPROVE NEAR VISION IN THE NON-DOMINANT EYE OF PRESBYOPIC HYPEROPES OR PRESBYOPIC EMMETROPES, VIA SPHERICAL HYPEROPIC TREATMENT OF 1.00 TO 2.25 D, IN PATIENTS: 1) 40 YEARS OF AGE OF GREATER; 2) WITH A DOCUMENTED STABILITY OF REFRACTION FOR THE PRIOR 12 MONTHS, AS DEMONSTRATED BY A CHANGE OF <0.50 D IN SPHERICAL AND CYLINDRICAL COMPONENTS OF THE MANIFEST REFRACTION; 3) WITH

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OPTIPOINT CORNEAL MARKER, MODEL VPT-OPT-450 (K053475)Refractec, Inc.2006-03-03
REFRACTEC MCS-100 (K980522)Refractec, Inc.1998-07-22